Non-invasive prenatal testing (NIPT) is a screening method for the early detection of foetal aneuploidies in
pregnant women. While originally developed for the detection of trisomy 13, 18 and 21, it is becoming clear
that NIPT can be used for the identification of rare foetal aneuploidies and mosaic aneuploidy as well. Here we
describe a female foetus with trisomy 21 in combination with mosaicism X0/XX, detected during follow-up of
an abnormal ultrasound (enlarged NT: 3,3 mm). Microarray analysis and FISH on chorion villi cells confirmed
trisomy 21, and mosaicism X0/XX (~29% of cells (n=63)). NIPT convincingly detected the presence of trisomy 21
with a Z-score of 22.9. (Partial) monosomy X on NIPT was revealed by the absence of a clear second X
chromosome on the sex plots and the high discrepancy between the foetal fraction of chromosome X and the
foetal fraction of chromosome Y. Likely the high seqFF value (16%) helped to more confidently identify these
aneuploidies. While the debate as to whether or not aneuploidies of the sex chromosomes should be reported
continues, this study shows that these aneuploidies can nevertheless be picked up, and probably other rare
genetic abnormalities as well.
Original languageEnglish
Title of host publicationTrisomy 21/mosaic Turner detected in fetus by non-invasive prenatal testing
Subtitle of host publicationHuman Genetics Goes Somatic
PublisherBelgian Society of Human Genetics
Number of pages1
Publication statusPublished - 17 Feb 2017
Event17th annual Belgian Society of Human Genetics meeting: Human genetics goes somatic - Louvain-la-Neuve, Aula Magna, Louvain-la-Neuve, Belgium
Duration: 17 Feb 201717 Feb 2017


Conference17th annual Belgian Society of Human Genetics meeting
Internet address


Dive into the research topics of 'Trisomy 21/mosaic Turner detected in fetus by non-invasive prenatal testing'. Together they form a unique fingerprint.

Cite this